InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Gergen Mark J, Chief Executive Officer. Insider active across 2 companies, notably Poseida Therapeutics, Inc.. Cumulatively, 13 filings have been recorded. Split: 0 buy · 1 sell. Activity tracked since 1 February 2022. The latest transaction was disclosed on 2 January 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations
Gergen Mark J is Chief Executive Officer and President. He has 13 filings in total, and across the sampled recent filings from 2016-01-19 to 2025-01-08, the most common transaction nature is tax withholding, with 0 EUR of buys and 0 EUR of sells. The recent filings relate to Poseida Therapeutics, Inc. and Mirati Therapeutics, Inc., and the highest individual amounts shown are 216197.6578972496 EUR, 205076.9536038622 EUR, 148855.6186500762 EUR, 130558.8137195851 EUR, 79880.8906335283 EUR and 79041.57872285784 EUR.